Abstract
Severe limitations such as cellular uptake efficiency, cell-specific delivery, stability against nucleases have impeded the use of oligonucleotides in therapy. The design of delivery strategies tha...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
